ASCO Brain Metastases Working Group Recommends Broadening Systemic Therapy Trial Criteria to Include Patients With Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Brain Metastases Working Group
J. Clin. Oncol 2017 Oct 02;[EPub Ahead of Print], NU Lin, T Prowell, AR Tan, M Kozak, O Rosen, L Amiri-Kordestani, J White, J Sul, L Perkins, K Beal, R Gaynor, ES KimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.